"Generex will declare a dividend in the company’s wholly-owned subsidiary, NuGenerex Immuno-Oncology (formerly Antigen Express). The dividend will be structured such that for every 4 shares of Generex stock held on February 25, 2019 (the projected dividend payment date), investors will receive 1 share of NuGenerex Immuno-Oncology. Immediately following the dividend payout, Generex plans to list NuGenerex Immuno-Oncology on a public exchange"
THIS IS THE MOST IMPORTANT NEWS....GREAT JOB MR. MOSCATO ....GREAT JOB
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links